TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alibaba Health Information Technology ( (HK:0241) ) has shared an update.
Alibaba Health Information Technology Limited has announced a revision of its annual caps for the 2025–2027 Marketing and Promotion Services Framework Agreement with Alimama. The revision is necessary as the original caps are insufficient to meet the business needs for the financial years ending March 31, 2027. This adjustment, which is subject to shareholder approval and compliance with Hong Kong’s Listing Rules, reflects the company’s strategic efforts to align its marketing and promotion services with its growth objectives.
The most recent analyst rating on (HK:0241) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare industry, focusing on providing digital health services and solutions. The company is a subsidiary of Alibaba Group, leveraging its technological capabilities to enhance healthcare services and accessibility.
Average Trading Volume: 112,592,870
Technical Sentiment Signal: Hold
Current Market Cap: HK$92.36B
Find detailed analytics on 0241 stock on TipRanks’ Stock Analysis page.